Chat with us, powered by LiveChat
3rd Clinical Trials Phase I & Phase IIA Summit - Philadelphia, PA

3rd Clinical Trials Phase I & Phase IIA Summit
October 18 - 19, 2016
Philadelphia, PA
Philadelphia, PA

Optimizing Early Phase Clinical Development Strategies While Increasing Efficiency and Cutting Costs

3rd Clinical Trials Phase I & Phase IIA Summit – 3rd Clinical Trials Phase I & Phase IIA Summit

With the rising cost of drugs and increasing regulations, it is essential for organizations to find ways to cut their development costs. Sponsors often focus on achieving regulatory compliance and speeding through early development so they can focus on Phase 3, where they incur the bulk of their development costs. This can cause them to sacrifice on innovative trial design and effective measures for collecting data on the safety and efficacy of a product.

The mission of the 3rd Clinical Trials Phase I & Phase IIA Summit is to provide attendees with the strategies and insight necessary to ensure early stage clinical trials are executed on time and within budget, and to help them explore how to leverage innovative approaches to managing clinical trials from the different therapeutic areas.

Top Reasons to Attend

  • Conduct the optimal Phase I study by improving communication between the site, sponsor and CRO
  • Hear practical considerations for integrating wearable biosensor enabled biomarkers in clinical research
  • Understand the revised ICH E14 Guideline and the impact of early QT assessments as an alternative to TQT studies
  • Identify the challenges of vendor qualification and learn how to increase the probability of a successful partnership
  • Discuss the different approaches to improving safety in early phase clinical trials
  • Examine the evolving challenges of identifying and recruiting special populations

Who You’ll Meet

This conference is designed for representatives from pharmaceutical, medical device and biotechnology companies with responsibilities in the following areas:

  • Clinical Operations
  • Early Phase Development
  • Pharmacology/Pharmacokinetics/Pharmacodynamics
  • Translational Science/Medicine
  • Biostatistics
  • Clinical Data Management
  • Clinical Innovation
  • Regulatory Affairs/Compliance
  • Patient Recruitment/Engagement
  • Drug Safety
live chat software